SEC Form 4 · accession 0001593968-17-000454
Avinger Inc · AVGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arjun Desai
Officer — Chief Medical Officer
Period of report
Mar 13, 2017
Accepted (ET)
Mar 15, 2017 · 8:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001506928
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 13, 2017 | A | 15,000 | — | A | 41,386 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F3 | $2.05 | Mar 13, 2017 | A | 30,000 | A | Mar 13, 2018 | Mar 13, 2027 | Common Stock | 30,000 | 172,683 | D |
Explanation of responses
- F1Reporting person received an award under the 2015 Equity Incentive Plan of RSUs with a grant date fair market value of $2.05 per share. The RSUs vest annually over four years in equal increments.
- F2Includes 33,750 shares of Avinger, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F3The stock options vest 25% on the first anniversary of the transaction date and monthly thereafter in 36 equal increments.